AI-generated summary
This review examines breast cancer treatment, with a focus on chemotherapy, and considers laser-based approaches such as low-level laser therapy, photochemotherapy, and photodynamic therapy as possible adjuncts. The authors report that these methods may modulate the tumor microenvironment, improve drug delivery, and enhance apoptosis, and that photodynamic therapy showed promise in localized cytotoxic effects. They note that heterogeneity in laser parameters and protocols is a significant barrier to clinical translation.
- Who or what was studied
- Women with breast cancer, including ductal carcinoma in situ, lobular carcinoma, and triple-negative breast cancer subtypes
- Limits stated in the abstract
- The abstract describes a narrative review and reports heterogeneity in laser parameters and treatment protocols, with no quantitative findings or included study count stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Breast cancer is one of the most prevalent and biologically diverse malignancies in women worldwide, encompassing subtypes such as ductal carcinoma in situ (DCIS), lobular carcinoma, and triple-negative breast cancer (TNBC). These variants present complex therapeutic challenges. Chemotherapy remains a core treatment modality, particularly in aggressive or advanced stages, yet its systemic toxicity and lack of specificity limit its efficacy. In recent years, laser-based therapies have emerged as adjunctive strategies to enhance therapeutic precision. This review explores breast cancer classification, progression, and treatment, with an emphasis on chemotherapy, and critically examines the emerging role of laser technologies, including low-level laser therapy (LLLT), Photochemotherapy, and Photodynamic Therapy (PDT), as adjunctive or alternative therapeutic options. We highlight the potential of laser to modulate the tumor microenvironment, improve drug delivery, regulate mitochondrial function, and enhance apoptosis. PDT showed promise in activating localized cytotoxic effects while sparing surrounding tissues. However, heterogeneity in laser parameters and treatment protocols remains a significant barrier to clinical translation. This review underscores the translational potential of laser-assisted chemotherapy, identifies current gaps, and suggests future research directions for optimized treatment strategies in breast oncology.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Photodynamic therapy, Low-level laser therapy, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.